Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hinterhuber

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 3, 2004
Incomplete improvement of visuo-motor deficits in patients with minimal hepatic encephalopathy after liver transplantationSergei Mechtcheriakov, Ivo W Graziadei, Michael Mattedi, et al.
Pharmacopsychiatry|November 1, 1988
First results of an open phase II study with the antidepressant paroxetineC Stuppäck, H Schubert, C Barnas, et al.
Journal of Clinical Psychopharmacology|August 1, 1994
A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatientsC H Stuppaeck, C Geretsegger, A B Whitworth, et al.
Journal of Breath Research|March 9, 2011
Isoprene and acetone concentration profiles during exercise on an ergometerJ King, A Kupferthaler, K Unterkofler, et al.
The European Journal of Neuroscience|September 30, 1998
Synaptic loss reflected by secretoneurin-like immunoreactivity in the human hippocampus in Alzheimer's diseaseW A Kaufmann, U Barnas, C Humpel, et al.
Wiener Klinische Wochenschrift|July 18, 1986
[Activation of the macrophage/lymphocyte system in AIDS, ARC and AIDS risk groups]H Wachter, H G Blecha, D Fuchs, et al.
Neuropsychobiology|March 3, 2006
Intravenous mirtazapine is safe and effective in the treatment of depressed inpatientsM Mühlbacher, A Konstantinidis, S Kasper, et al.
Cancer Detection and Prevention|January 1, 1988
Is T-cell activation an unfavourable sign in i.v.-drug addicts infected with HIV?D N Fuchs, A Hausen, P Hengster, et al.
Lancet (London, England)|June 29, 1985
High frequency of HTLV-III antibodies among heterosexual intravenous drug abusers in the Austrian TyrolD Fuchs, H G Blecha, F Deinhardt, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1988
Anti-HIV-1 antibodies, anti-HTLV-I antibodies and neopterin levels in parenteral drug addicts in the Austrian TyrolD Fuchs, B Unterweger, A Hausen, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 3, 2004
Incomplete improvement of visuo-motor deficits in patients with minimal hepatic encephalopathy after liver transplantationSergei Mechtcheriakov, Ivo W Graziadei, Michael Mattedi, et al.
Pharmacopsychiatry|November 1, 1988
First results of an open phase II study with the antidepressant paroxetineC Stuppäck, H Schubert, C Barnas, et al.
Journal of Clinical Psychopharmacology|August 1, 1994
A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatientsC H Stuppaeck, C Geretsegger, A B Whitworth, et al.
Journal of Breath Research|March 9, 2011
Isoprene and acetone concentration profiles during exercise on an ergometerJ King, A Kupferthaler, K Unterkofler, et al.
The European Journal of Neuroscience|September 30, 1998
Synaptic loss reflected by secretoneurin-like immunoreactivity in the human hippocampus in Alzheimer's diseaseW A Kaufmann, U Barnas, C Humpel, et al.
Wiener Klinische Wochenschrift|July 18, 1986
[Activation of the macrophage/lymphocyte system in AIDS, ARC and AIDS risk groups]H Wachter, H G Blecha, D Fuchs, et al.
Neuropsychobiology|March 3, 2006
Intravenous mirtazapine is safe and effective in the treatment of depressed inpatientsM Mühlbacher, A Konstantinidis, S Kasper, et al.
Cancer Detection and Prevention|January 1, 1988
Is T-cell activation an unfavourable sign in i.v.-drug addicts infected with HIV?D N Fuchs, A Hausen, P Hengster, et al.
Lancet (London, England)|June 29, 1985
High frequency of HTLV-III antibodies among heterosexual intravenous drug abusers in the Austrian TyrolD Fuchs, H G Blecha, F Deinhardt, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1988
Anti-HIV-1 antibodies, anti-HTLV-I antibodies and neopterin levels in parenteral drug addicts in the Austrian TyrolD Fuchs, B Unterweger, A Hausen, et al.
Pageof 10